Publication | Open Access

Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)

UrologyOncologyAbiraterone AcetateMedicinePharmacotherapyCancer TreatmentProstatic DiseasePharmacologyInterim Efficacy AnalysisPrior Chemotherapy